How many patents cover ofloxacin ophthalmic solution?
The exact number of patents “available” for ofloxacin ophthalmic solution depends on how broadly you define the scope (for example: only ophthalmic formulations vs. any ophthalmic use of ofloxacin; original patents vs. family members worldwide; granted patents vs. published applications; whether you include combination products). The provided information does not include patent-count data or search results that would let a precise number be stated.
Where the count usually comes from (and why totals vary)
Patent totals can vary widely because databases and search strategies differ. Typical choices that change the number you get include:
- Jurisdiction: USPTO only vs. worldwide (EPO, WIPO/Patentscope, China, etc.).
- Document type: granted patents only vs. published applications included.
- Keyword strategy: “ofloxacin” + “ophthalmic solution” vs. broader terms like “topical ocular,” “eye drops,” “ophthalmic,” or specific formulation names.
- Patent family handling: counting each document record vs. counting each distinct invention family once.
What I need to give you a precise number
If you want an exact count, tell me:
1) Which database(s) to use (USPTO, Google Patents, Lens.org, WIPO/Patentscope, EPO, etc.)
2) Which jurisdictions (US only or worldwide)
3) Whether to count granted patents only or also published applications
4) What scope you want (ofloxacin ophthalmic solution specifically, or also ofloxacin eye drops/ocular solutions and combinations like with steroids/antibiotics)
If you share those details, I can return the count
Once you confirm the scope and database/jurisdiction, I can produce a number of relevant patent documents (and optionally a breakdown by country, year, and whether they’re granted or applications).
Sources
No patent sources were provided with the question, so I can’t cite or verify a specific patent total.